keyword
https://read.qxmd.com/read/38652878/trans-ancestral-genetic-risk-factors-for-treatment-related-type-2-diabetes-mellitus-in-survivors-of-childhood-cancer
#1
JOURNAL ARTICLE
Cindy Im, Achal Neupane, Jessica L Baedke, Brian Lenny, Angela Delaney, Stephanie B Dixon, Eric J Chow, Sogol Mostoufi-Moab, Tianzhong Yang, Melissa A Richard, M Monica Gramatges, Philip J Lupo, Noha Sharafeldin, Smita Bhatia, Gregory T Armstrong, Melissa M Hudson, Kirsten K Ness, Leslie L Robison, Yutaka Yasui, Carmen L Wilson, Yadav Sapkota
PURPOSE: Type 2 diabetes mellitus (T2D) is a prevalent long-term complication of treatment in survivors of childhood cancer, with marked racial/ethnic differences in burden. In this study, we investigated trans-ancestral genetic risks for treatment-related T2D. PATIENTS AND METHODS: Leveraging whole-genome sequencing data from the St Jude Lifetime Cohort (N = 3,676, 304 clinically ascertained cases), we conducted ancestry-specific genome-wide association studies among survivors of African and European genetic ancestry (AFR and EUR, respectively) followed by trans-ancestry meta-analysis...
April 23, 2024: Journal of Clinical Oncology
https://read.qxmd.com/read/38652574/3-o-substituted-quercetin-an-antibiotic-potentiating-agent-against-multidrug-resistant-gram-negative-enterobacteriaceae-through-simultaneous-inhibition-of-efflux-pump-and-broad-spectrum-carbapenemases
#2
JOURNAL ARTICLE
Taegum Lee, Seongyeon Lee, Mi Kyoung Kim, Joong Hoon Ahn, Ji Sun Park, Hwi Won Seo, Ki-Ho Park, Youhoon Chong
The discovery of safe and efficient inhibitors against efflux pumps as well as metallo-β-lactamases (MBL) is one of the main challenges in the development of multidrug-resistant (MDR) reversal agents which can be utilized in the treatment of carbapenem-resistant Gram-negative bacteria. In this study, we have identified that introduction of an ethylene-linked sterically demanding group at the 3-OH position of the previously reported MDR reversal agent di-F-Q endows the resulting compounds with hereto unknown multitarget inhibitory activity against both efflux pumps and broad-spectrum β-lactamases including difficult-to-inhibit MBLs...
April 23, 2024: ACS Infectious Diseases
https://read.qxmd.com/read/38652480/navigating-the-tumor-microenvironment-mesenchymal-stem-cell-mediated-delivery-of-anticancer-agents
#3
REVIEW
Muhammad Ahsan Waqar, Muhammad Zaman, Muhammad ShafeeqUrRahman, Rabeel Khan, Imtiaz Majeed
Scientific knowledge of cancer has advanced greatly throughout the years, with most recent studies findings includes many hallmarks that capture disease's multifaceted character. One of the novel approach utilized for the delivery of anti-cancer agents includes mesenchymal stem cell mediated drug delivery. Mesenchymal stem cells (MSCs) are non-hematopoietic progenitor cells that may be extracted from bone marrow, tooth pulp, adipose tissue and placenta/umbilical cord blood dealing with adult stem cells. MSCs are mostly involved in regeneration of tissue, they have also been shown to preferentially migrate to location of several types of tumor in-vivo ...
April 23, 2024: Journal of Drug Targeting
https://read.qxmd.com/read/38652454/role-of-mucositis-in-predicting-gut-microbiota-composition-in-people-with-cancer
#4
JOURNAL ARTICLE
Jacqui S Scott, Anna Li, Hannah R Wardill
PURPOSE OF REVIEW: Disruption of the precious ecosystem of micro-organisms that reside in the gut - the gut microbiota - is rapidly emerging as a key driver of adverse side effects/toxicities caused by numerous anti-cancer agents. Although the contribution of the gut microbiota to these toxicities is understood with ever increasing precision, the cause of microbial disruption (dysbiosis) remains poorly understood. Here, we discuss current evidence on the cause(s) of dysbiosis after cancer therapy, positioning breakdown of the intestinal mucosa (mucositis) as a central cause...
April 23, 2024: Current Opinion in Supportive and Palliative Care
https://read.qxmd.com/read/38652366/design-synthesis-and-structure-activity-relationship-study-of-novel-plinabulin-derivatives-as-anti-tumor-agents-based-on-the-co-crystal-structure
#5
JOURNAL ARTICLE
Shixiao Wang, Changjiang Zhong, Feifei Li, Zhongpeng Ding, Yu Tang, Wenbao Li
Plinabulin, a 2, 5-diketopiperazine-type tubulin inhibitor derived from marine natural products, is currently undergoing Phase III clinical trials for the treatment of non-small cell lung cancer (NSCLC) and chemotherapy-induced neutropenia (CIN). To obtain novel 2, 5-diketopiperazine derivatives with higher biological activity, we designed and synthesized two series of 37 plinabulin derivatives at the C-ring, based on the co-crystal structure of compound 1 and tubulin. Their structures were characterized using NMR and HRMS...
April 23, 2024: Molecular Diversity
https://read.qxmd.com/read/38652358/a-novel-enhanced-fluorescent-probe-based-on-dhla-stabilized-red-emitting-copper-nanoclusters-for-methimazole-detection-via-aggregation-induced-emission-effect
#6
JOURNAL ARTICLE
Qikun Zhang, Jingyi Duan, Jinwen Chen, Juan Du, Huixiao Tong, Shenghua Liao
Herein, an aqueous phase synthesis approach was presented for the fabrication of copper nanoclusters (Cu NCs) with aggregation-induced emission (AIE) property, utilizing lipoic acid and NaBH4 as ligands and reducing agent, respectively. The as-synthesized Cu NCs exhibit an average size of 3.0 ± 0.2 nm and demonstrate strong solid-state fluorescence upon excitation with UV light. However, when dissolved in water, no observable fluorescent emission is detected in the aqueous solution of Cu NCs...
April 23, 2024: Journal of Fluorescence
https://read.qxmd.com/read/38652344/comprehensive-review-of-the-repositioning-of-non-oncologic-drugs-for-cancer-immunotherapy
#7
REVIEW
Abdur Rauf, Payal B Joshi, Ahmed Olatunde, Nabia Hafeez, Zubair Ahmad, Hassan A Hemeg, Abdullah S M Aljohani, Waleed Al Abdulmonem, Muthu Thiruvengadam, Dhivya Viswanathan, Govindasamy Rajakumar, Rekha Thiruvengadam
Drug repositioning or repurposing has gained worldwide attention as a plausible way to search for novel molecules for the treatment of particular diseases or disorders. Drug repurposing essentially refers to uncovering approved or failed compounds for use in various diseases. Cancer is a deadly disease and leading cause of mortality. The search for approved non-oncologic drugs for cancer treatment involved in silico modeling, databases, and literature searches. In this review, we provide a concise account of the existing non-oncologic drug molecules and their therapeutic potential in chemotherapy...
April 23, 2024: Medical Oncology
https://read.qxmd.com/read/38652292/ion-uptake-in-naturally-acidic-water
#8
REVIEW
R J Gonzalez, M L Patrick, A L Val
The first studies on ion regulation in fish exposed to low pH, which were inspired by the Acid Rain environmental crisis, seemed to indicate that ion transport at the gills was completely and irreversibly inhibited at pH 4.0-4.5 and below. However, work on characid fish native to the Rio Negro, a naturally acidic, blackwater tributary of the Amazon River, found that they possess ion transport mechanisms that are completely insensitive to pHs as low as 3.25. As more species were examined it appeared that pH-insensitive transport was a trait shared by many, if not most, species in the Order Characiformes...
April 23, 2024: Journal of Comparative Physiology. B, Biochemical, Systemic, and Environmental Physiology
https://read.qxmd.com/read/38652207/anti-cancer-potential-of-zerumbone-in-cancer-and-glioma-current-trends-and-future-perspectives
#9
REVIEW
Alborz Soroush, Siavash Pourhossein, Dorrin Hosseingholizadeh, Ahmed Hjazi, Reza Shahhosseini, Haniyeh Kavoosi, Nazgol Kermanshahi, Parisa Behnamrad, Nima Ghavamikia, Mehdi Dadashpour, Sepideh Karkon Shayan
Plant-derived immunomodulators and antitumor factors have appealed lots of attention from natural product scientists for their efficiency and safety and their important contribution to well-designed targeted drug action and delivery mechanisms. Zerumbone (ZER), the chief component of Zingiber zerumbet rhizomes, has been examined for its wide-spectrum in the treatment of multi-targeted diseases. The rhizomes have been used as food flavoring agents in numerous cuisines and in flora medication. Numerous in vivo and in vitro experiments have prepared confirmation of ZER as a potent immunomodulator as well as a potential anti-tumor agent...
April 23, 2024: Medical Oncology
https://read.qxmd.com/read/38652202/developing-a-novel-enzalutamide-resistant-prostate-cancer-model-via-ar-f877l-mutation-in-lncap-cells
#10
JOURNAL ARTICLE
Ruifeng Wang, Shuhua Ma, Nengwei Xu, Yumiao Gan, Pengya Li, Jingying Zhang, Zhixiang Zhang, Qingyang Gu, Jian Xiang
Prostate cancer is a leading diagnosis and major cause of cancer-related deaths in men worldwide. As a typical hormone-responsive disease, prostate cancer is commonly managed with androgen deprivation therapy (ADT) to curb its progression and potential metastasis. Unfortunately, progression to castration-resistant prostate cancer (CRPC), a notably more aggressive phase of the disease, occurs within a timeframe of 2-3 years following ADT. Enzalutamide, a recognized androgen receptor (AR) antagonist, has been employed as a standard of care for men with metastatic castration-resistant prostate cancer (mCRPC) since it was first approved in 2012, due to its ability to prolong survival...
April 2024: Current protocols
https://read.qxmd.com/read/38652189/siderophore-producing-bacteria-from-spitsbergen-soils-novel-agents-assisted-in-bioremediation-of-the-metal-polluted-soils
#11
JOURNAL ARTICLE
Małgorzata Majewska, Anna Słomka, Agnieszka Hanaka
Siderophores are molecules that exhibit a high specificity for iron (Fe), and their synthesis is induced by a deficiency of bioavailable Fe. Complexes of Fe-siderophore are formed extracellularly and diffuse through porins across membranes into bacterial cells. Siderophores can bind heavy metals facilitating their influx into cells via the same mechanism. The aim of the studies was to determine the ability of siderophore-producing bacteria isolated from soils in the north-west part of Wedel Jarlsberg Land (Spitsbergen) to chelate non-Fe metals (Al, Cd, Co, Cu, Hg, Mn, Sn, and Zn)...
April 23, 2024: Environmental Science and Pollution Research International
https://read.qxmd.com/read/38651884/identification-and-characterization-of-a-novel-antifungal-compound-tubeimoside-i-targeting-cell-wall
#12
JOURNAL ARTICLE
Qiannan Liu, Zhiqi Zhong, Shunxin Zheng, Yunzhuo Chu, Norihiro Sakamoto, Takayoshi Kuno, Yue Fang
UNLABELLED: Due to fungal diseases that threaten immunocompromised patients, along with the limited availability of antifungal agents, there is an urgent need for new antifungal compounds to treat fungal infections. Here, we aimed to identify potential antifungal drugs from natural products using the fission yeast Schizosaccharomyces pombe as a model organism since it shares many features with some pathogenic fungi. Here, we identified tubeimoside I (TBMS1), an extract from Chinese herbal medicine, that showed strong antifungal activity against S...
April 23, 2024: Microbiology Spectrum
https://read.qxmd.com/read/38651882/novel-antimony-based-antimicrobial-drug-targets-membranes-of-gram-positive-and-gram-negative-bacterial-pathogens
#13
JOURNAL ARTICLE
Tarosha Salpadoru, Kevin E Pinks, Jacob A Lieberman, Kaitlyn Cotton, Karen L Wozniak, Nikolay Gerasimchuk, Marianna A Patrauchan
UNLABELLED: Antimicrobial resistance (AMR) poses a significant worldwide public health crisis that continues to threaten our ability to successfully treat bacterial infections. With the decline in effectiveness of conventional antimicrobial therapies and the lack of new antibiotic pipelines, there is a renewed interest in exploring the potential of metal-based antimicrobial compounds. Antimony-based compounds with a long history of use in medicine have re-emerged as potential antimicrobial agents...
April 23, 2024: Microbiology Spectrum
https://read.qxmd.com/read/38651823/targeting-bacterial-growth-in-biofilm-conditions-rational-design-of-novel-inhibitors-to-mitigate-clinical-and-food-contamination-using-qsar
#14
JOURNAL ARTICLE
Maria Galvez-Llompart, Jesús Hierrezuelo, Mariluz Blasco, Riccardo Zanni, Jorge Galvez, Antonio de Vicente, Alejandro Pérez-García, Diego Romero
Antimicrobial resistance (AMR) is a pressing global issue exacerbated by the abuse of antibiotics and the formation of bacterial biofilms, which cause up to 80% of human bacterial infections. This study presents a computational strategy to address AMR by developing three novel quantitative structure-activity relationship (QSAR) models based on molecular topology to identify potential anti-biofilm and antibacterial agents. The models aim to determine the chemo-topological pattern of Gram (+) antibacterial, Gram (-) antibacterial, and biofilm formation inhibition activity...
December 2024: Journal of Enzyme Inhibition and Medicinal Chemistry
https://read.qxmd.com/read/38651692/discovery-of-c-linked-nucleoside-analogues-with-antiviral-activity-against-sars-cov-2
#15
JOURNAL ARTICLE
Eugen F Mesaros, Benjamin J Dugan, Min Gao, Muhammad Sheraz, Kayleigh McGovern-Gooch, Fran Xu, Kristi Yi Fan, Duyan Nguyen, Steven G Kultgen, Aaron Lindstrom, Kim Stever, Breanna Tercero, Randall J Binder, Fei Liu, Holly M Micolochick Steuer, Nagraj Mani, Troy O Harasym, Emily P Thi, Andrea Cuconati, Bruce D Dorsey, Andrew G Cole, Angela M Lam, Michael J Sofia
The recent COVID-19 pandemic underscored the limitations of currently available direct-acting antiviral treatments against acute respiratory RNA-viral infections and stimulated major research initiatives targeting anticoronavirus agents. Two novel nsp5 protease (MPro) inhibitors have been approved, nirmatrelvir and ensitrelvir, along with two existing nucleos(t)ide analogues repurposed as nsp12 polymerase inhibitors, remdesivir and molnupiravir, but a need still exists for therapies with improved potency and systemic exposure with oral dosing, better metabolic stability, and reduced resistance and toxicity risks...
April 23, 2024: ACS Infectious Diseases
https://read.qxmd.com/read/38651512/an-update-on-topical-therapies-for-psoriasis
#16
JOURNAL ARTICLE
Emily K Pender, Brian Kirby
PURPOSE OF REVIEW: Topical therapies are a mainstay of treatment for mild psoriasis and may be a useful adjunct in treatment of moderate-to-severe psoriasis. This review summarizes recent advances in topical therapies for psoriasis and currently available treatments. RECENT FINDINGS: Topical aryl hydrocarbon receptor modulators (tapinarof) and topical phosphodiesterase-4 inhibitors (roflumilast) have been proven effective in randomized controlled trials for psoriasis...
April 24, 2024: Current Opinion in Rheumatology
https://read.qxmd.com/read/38651488/novel-pseudomonas-species-prevent-the-growth-of-the-phytopathogenic-fungus-aspergillus-flavus
#17
JOURNAL ARTICLE
Franciene Rabiço, Tiago Cabral Borelli, Robson Carlos Alnoch, Maria de Lourdes Teixeira de Moraes Polizeli, Ricardo R da Silva, Rafael Silva-Rocha, María-Eugenia Guazzaroni
In response to the escalating demand for sustainable agricultural methodologies, the utilization of microbial volatile organic compounds (VOCs) as antagonists against phytopathogens has emerged as a viable eco-friendly alternative. Microbial volatiles exhibit rapid diffusion rates, facilitating prompt chemical interactions. Moreover, microorganisms possess the capacity to emit volatiles constitutively, as well as in response to biological interactions and environmental stimuli. In addition to volatile compounds, these bacteria demonstrate the ability to produce soluble metabolites with antifungal properties, such as APE Vf, pyoverdin, and fragin...
March 30, 2024: BioTech (Basel)
https://read.qxmd.com/read/38651451/monitoring-humoral-response-following-bnt162b2-mrna-vaccination-against-sars-cov-2-in-hematopoietic-stem-cell-transplantation-patients-a-single-center-prospective-study-along-with-a-brief-review-of-current-literature
#18
JOURNAL ARTICLE
John V Asimakopoulos, Eleni Lalou, George Seferlis, Maria Malliarou, Eliana Konstantinou, Ioannis Drandakis, Ioannis Vasilopoulos, Angeliki N Georgopoulou, Anastasia Kopsaftopoulou, Alexandros Machairas, Alexia Piperidou, Anestis Karapaschalidis, Maria-Ekaterini Lefaki, Dimitrios Galopoulos, Maria-Panagiota Arapaki, Panagiota Petsa, Ekaterini Benekou, Marina P Siakantaris, Athanasios G Papavassiliou, Panagiotis Tsaftaridis, Panayiotis Panayiotidis, Theodoros P Vassilakopoulos, Angeliki Papapanagiotou, Maria K Angelopoulou
Data on antibody response (AR) after vaccination against SARS-CoV2 in hematopoietic stem-cell transplantation setting (HSCT) were initially scarce, mainly due to the exclusion of such patients from approval studies. Shortly after the worldwide application of vaccination against SARS-CoV-2 in vulnerable populations such as patients with hematologic malignancies, limited single-center trials, including HSCT patients, were published. However, there was a great heterogeneity between them regarding the type of underlying malignancy, co-current treatment, type of vaccine, method of AR measurement, and time point of AR measurement...
April 16, 2024: Hematology Reports
https://read.qxmd.com/read/38651247/deinococcus-wulumuqiensis-r12-synthesized-silver-nanoparticles-with-peroxidase-like-activity-for-synergistic-antibacterial-application
#19
JOURNAL ARTICLE
Jingjia Liu, Nan Zhang, Bowen Shen, Liling Zhang, Zhidong Zhang, Liying Zhu, Ling Jiang
The use of a combination of several antibacterial agents for therapy holds great promise in reducing the dosage and side effects of these agents, improving their efficiency, and inducing potential synergistic therapeutic effects. Herein, this study provides an innovative antibacterial treatment strategy by synergistically combining R12-AgNPs with H2 O2 therapy. R12-AgNPs were simply produced with the supernatant of an ionizing radiation-tolerant bacterium Deinococcus wulumuqiensis R12 by one-step under room temperature...
April 2024: Biotechnology Journal
https://read.qxmd.com/read/38650871/from-predator-to-protector-myxococcus-fulvus-wch05-emerges-as-a-potent-biocontrol-agent-for-fire-blight
#20
JOURNAL ARTICLE
Jian Han, Zhiming Dong, Wenbo Ji, Wen Lv, Ming Luo, Benzhong Fu
Fire blight, caused by the Gram-negative bacterium Erwinia amylovora , poses a substantial threat to pome fruit production worldwide. Despite existing control strategies, a pressing need remains for sustainable and environmentally friendly fire blight management. Myxobacteria, renowned for their predatory behavior and potent enzymes, emerge as a groundbreaking biocontrol approach with significant potential. Here, we report the biocontrol potential of a novel Myxococcus fulvus WCH05, against E. amylovora . Using various in vitro and planta assays, we demonstrated the multifaceted biocontrol abilities of strain WCH05...
2024: Frontiers in Microbiology
keyword
keyword
30451
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.